Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCQ | Q04759 | 10/20 | 0.84 |
| ▸ | ROCK2 | O75116 | 9/20 | 0.79 |
| ▸ | PRKCA | P17252 | 7/20 | 0.59 |
| ▸ | MAP3K5 | Q99683 | 2/20 | 0.56 |
| ▸ | CDK4 | P11802 | 3/20 | 0.55 |
| ▸ | CCND1 | P24385 | 2/20 | 0.55 |
| ▸ | PIM1 | P11309 | 1/20 | 0.53 |
| ▸ | FLT3 | P36888 | 1/20 | 0.53 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.53 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.53 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.52 |
| ▸ | PRKCG | P05129 | 3/20 | 0.52 |
| ▸ | PRKCB | P05771 | 3/20 | 0.52 |
| ▸ | PRKCH | P24723 | 3/20 | 0.52 |
| ▸ | PRKCI | P41743 | 3/20 | 0.52 |
| ▸ | PRKCE | Q02156 | 3/20 | 0.52 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.52 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.52 |
| ▸ | PRKD1 | Q15139 | 3/20 | 0.52 |
| ▸ | CDK2 | P24941 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12570605 | 1.00 | PRKCQ (0.84) | PRKCQROCK2PRKCAMAP3K5CDK4 | |
| SCHEMBL12570607 | 1.00 | PRKCQ (0.84) | PRKCQROCK2PRKCAMAP3K5CDK4 | |
| SCHEMBL12570606 | 0.88 | PRKCQ (0.85) | PRKCQROCK2PRKCAMAP3K5 | |
| SCHEMBL12570349 | 0.88 | PRKCQ (0.85) | PRKCQROCK2PRKCAMAP3K5 | |
| SCHEMBL19050455 | 0.88 | PRKCQ (0.66) | PRKCQROCK2PRKCAMAP3K5CDK4 | |
| SCHEMBL18635358 | 0.88 | PRKCQ (0.66) | PRKCQROCK2PRKCAMAP3K5CDK4 | |
| SCHEMBL18635718 | 0.88 | PRKCQ (0.79) | PRKCQROCK2PRKCAMAP3K5 | |
| SCHEMBL12570608 | 0.88 | PRKCQ (0.85) | PRKCQROCK2PRKCAMAP3K5 | |
| SCHEMBL22197322 | 0.87 | PRKCQ (0.70) | PRKCQROCK2PRKCAMAP3K5CDK4 | |
| SCHEMBL18635724 | 0.87 | PRKCQ (0.69) | PRKCQROCK2PRKCAMAP3K5CDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3184537-B1 | GLYCOSYLATED INDOLOCARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | UNIV OVIEDO (ES) | 2020-07-08 | — | — | EP | disclosed |
| EP-3184537-A1 | GLYCOSYLATED INDOLOCARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | Universidad De Oviedo (ES) | 2017-06-28 | — | — | EP | disclosed |
| EP-2277885-B1 | GLYCOSYLATED INDOLECARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | UNIV OVIEDO (ES) | 2017-03-15 | — | — | EP | disclosed |
| US-20110136753-A1 | GLYCOSYLATED INDOLECARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | UNIVERSIDAD DE OVIEDO (ES) | 2011-06-09 | — | — | US | disclosed |
| EP-2277885-A1 | GLYCOSYLATED INDOLECARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | Universidad De Oviedo (ES) | 2011-01-26 | — | — | EP | disclosed |
| WO-2009125042-A1 | GLYCOSYLATED INDOLECARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | UNIVERSIDAD DE OVIEDO (ES) | 2009-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136753-A1 | GLYCOSYLATED INDOLECARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | PYGB, INMT, SI | PRKCQ 2262/4885ROCK2 315/4885PRKCA 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.